Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
Comparison of PET/CT vs. PET/MRI
Sponsor: Stanford University
A PHASE2 clinical study on Cancer Diagnosis and Diagnostic Imaging, this trial is completed. The trial is conducted by Stanford University and has accumulated 11 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
May 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2021 — May 2021 [monthly]
Completed PHASE2
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE2
Status: Suspended → Completed
▶ Show 6 earlier versions
-
Feb 2020 — Sep 2020 [monthly]
Suspended PHASE2
-
Sep 2019 — Feb 2020 [monthly]
Suspended PHASE2
Phase: NA → PHASE2
-
Nov 2018 — Sep 2019 [monthly]
Suspended NA
-
Jun 2018 — Nov 2018 [monthly]
Suspended NA
-
Aug 2017 — Jun 2018 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Jun 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .